(Q37226114)

19 August 2017

1 reference

title

Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa (English)

1 reference

19 August 2017

0 references

anti-retroviral agent

0 references

0 references

5

William J Moss

1 reference

19 August 2017

4

Deborah Persaud

1 reference

19 August 2017

author name string

Catherine G Sutcliffe

series ordinal

1

1 reference

19 August 2017

Janneke H van Dijk

series ordinal

2

1 reference

19 August 2017

Carolyn Bolton

series ordinal

3

1 reference

19 August 2017

publication date

1 August 2008

1 reference

Lancet Infectious Diseases

19 August 2017

published in

1 reference

19 August 2017

volume

8

1 reference

19 August 2017

issue

8

1 reference

19 August 2017

page(s)

477-489

1 reference

Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Preventing antiretroviral anarchy in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Antiretroviral therapy in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Care and treatment of HIV-infected children in Africa: issues and challenges at the district hospital level

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Doctors' attitudes to the care of children with HIV in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Genotypic human immunodeficiency virus type 1 drug resistance in highly active antiretroviral therapy-treated children in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Assessment of adherence to highly active antiretroviral therapy in a cohort of African HIV-infected children in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Respiratory manifestations in HIV-infected children pre- and post-HAART in Abidjan, the Ivory Coast

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Outcomes of HIV-infected orphaned and non-orphaned children on antiretroviral therapy in western Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Efficacy of highly active antiretroviral therapy in HIV-infected, institutionalized orphaned children in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Addressing the paediatric HIV epidemic: a perspective from the Western Cape Region of South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Adherence to antiretroviral therapy in children attending Mulago Hospital, Kampala

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Antiretroviral therapy for children in the routine setting in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Risk factors for early mortality in children on adult fixed-dose combination antiretroviral treatment in a central hospital in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Immune repopulation after HAART in previously untreated HIV-1-infected children. Paediatric European Network for Treatment of AIDS (PENTA) Steering Committee.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Viral load and CD4+ T lymphocyte response to highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children: an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Long-term effectiveness of highly active antiretroviral therapy (HAART) in perinatally HIV-infected children in Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Results of 2 years of treatment with protease-inhibitor--containing antiretroviral therapy in dutch children infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Outcomes for human immunodeficiency virus-1-infected infants in the United kingdom and Republic of Ireland in the era of effective antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Long-Term Effects of Highly Active Antiretroviral Therapy in Pretreated, Vertically HIV Type 1-Infected Children: 6 Years of Follow-Up

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Survival of HIV-1 and HIV-2 perinatally infected children in The Gambia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Morbidity among human immunodeficiency virus-1-infected and -uninfected African children.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Low immunologic response to highly active antiretroviral therapy in naive vertically human immunodeficiency virus type 1-infected children with severe immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Treatment outcomes stratified by baseline immunological status among young children receiving nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resource-limited settings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

CD4 Cell Response to Antiretroviral Therapy in Children with Vertically Acquired HIV Infection: Is It Associated with Age at Initiation?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Antiretroviral therapy for children: challenges and opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Early diagnosis of human immunodeficiency virus in infants using polymerase chain reaction on dried blood spots in Botswana's national program for prevention of mother-to-child transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Ultrasensitive quantitative HIV-1 p24 antigen assay adapted to dried plasma spots to improve treatment monitoring in low-resource settings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Case management of HIV-infected severely malnourished children: challenges in the area of highest prevalence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected african children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Antiretroviral therapy: what about food?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

How far should they walk? Increasing antiretroviral therapy access in a rural community in northern KwaZulu-Natal, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970180-4

7 January 2021

10.1016/S1473-3099(08)70180-4

Identifiers

DOI

1 reference

19 August 2017

1 reference